A fierce debate has erupted over investment-linked insurance plans.

Are ILPs misunderstood tools for long-term wealth, or overly complex, high-cost products investors should avoid?

Christopher Tan, CEO of Providend, returns to address his criticisms of his arguments following his Business Times column, which challenged the value of ILPs.

He breaks down industry rebuttals on compounding bonuses, adviser fees, and fund access, and explains why his firm continues to steer clear of them.

Hear both sides of the ILP story, from consumer confusion to claims of strategic tax and estate planning benefits - and decide where you stand.

Hosted by Michelle Martin.

See omnystudio.com/listener for privacy information.